Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Neuroimmunol ; 265(1-2): 96-105, 2013 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-24094461

RESUMO

UNLABELLED: Immunologic dysfunction, mediated via monocyte activity, has been implicated in the development of HIV-associated neurocognitive disorder (HAND). We hypothesized that transcriptome changes in peripheral blood monocytes relate to neurocognitive functioning in HIV+ individuals, and that such alterations could be useful as biomarkers of worsening HAND. METHODS: mRNA was isolated from the monocytes of 86 HIV+ adults and analyzed with the Illumina HT-12 v4 Expression BeadChip. Neurocognitive functioning, HAND diagnosis, and other clinical and virologic variables were determined. Data were analyzed using standard expression analysis and weighted gene co-expression network analysis (WGCNA). RESULTS: Neurocognitive functioning was correlated with multiple gene transcripts in the standard expression analysis. WGCNA identified two nominally significant co-expression modules associated with neurocognitive functioning, which were enriched with genes involved in mitotic processes and translational elongation. CONCLUSIONS: Multiple modified gene transcripts involved in inflammation, cytoprotection, and neurodegeneration were correlated with neurocognitive functioning. The associations were not strong enough to justify their use as biomarkers of HAND; however, the associations of two co-expression modules with neurocognitive functioning warrant further exploration.


Assuntos
Transtornos Cognitivos/etiologia , Regulação da Expressão Gênica/fisiologia , Infecções por HIV , Leucócitos Mononucleares/metabolismo , Leucócitos Mononucleares/virologia , Adulto , Idoso , Antígenos CD4/metabolismo , Transtornos Cognitivos/virologia , Depressão/etiologia , Depressão/virologia , Feminino , Perfilação da Expressão Gênica/métodos , Redes Reguladoras de Genes/genética , Infecções por HIV/sangue , Infecções por HIV/complicações , Infecções por HIV/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Análise de Sequência com Séries de Oligonucleotídeos , RNA Mensageiro/metabolismo , Estatística como Assunto
2.
J Leukoc Biol ; 94(4): 835-43, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23817564

RESUMO

In vivo and in vitro exposure to stimulants has been associated with increased levels of HIV infection in PBMCs. Among these lymphocyte subsets, quiescent CD4(+) T cells make up the majority of circulating T cells in the blood. Others and we have demonstrated that HIV infects this population of cells inefficiently. However, minor changes in their cell state can render them permissive to infection, significantly impacting the viral reservoir. We have hypothesized that stimulants, such as cocaine, may perturb the activation state of quiescent cells enhancing permissiveness to infection. Quiescent T cells isolated from healthy human donors were exposed to cocaine and infected with HIV. Samples were harvested at different time-points to assess the impact of cocaine on their susceptibility to infection at various stages of the HIV life cycle. Our data show that a 3-day exposure to cocaine enhanced infection of quiescent cells, an effect that appears to be mediated by σ1R and D4R. Overall, our results indicate that cocaine-mediated effects on quiescent T cells may increase the pool of infection-susceptible T cells. The latter underscores the impact that stimulants have on HIV-seropositive individuals and the challenges posed for treatment.


Assuntos
Cocaína/farmacologia , Infecções por HIV/patologia , HIV/fisiologia , Linfócitos T/virologia , Internalização do Vírus/efeitos dos fármacos , HIV/efeitos dos fármacos , Humanos , Cinética , Fenótipo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores de Dopamina D4/metabolismo , Receptores sigma/metabolismo , Transcrição Reversa/efeitos dos fármacos , Linfócitos T/efeitos dos fármacos , Proteínas Virais/genética , Proteínas Virais/metabolismo , Receptor Sigma-1
3.
Am J Physiol Endocrinol Metab ; 303(4): E542-50, 2012 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-22713506

RESUMO

The present study was designed to examine the effects of short-term diet and exercise on markers of metabolic health, serum-stimulated production of inflammatory biomarkers from cultured monocytes and adipocytes, and serum lipomics. Twenty-one overweight/obese children (9 boys and 12 girls, age 13.0 ± 0.5 yr, BMI 33.0 ± 1.8 kg/m(2)) were placed on a 2-wk ad libitum, high-fiber, low-fat diet and daily exercise regimen. Fasting serum samples were taken pre- and postintervention for determination of cytokines, metabolic risk markers, and lipomics. Monocytes and adipocytes were incubated with pre- and postintervention serum to investigate changes in cytokine secretion. Correlative associations were calculated, followed by hierarchical clustering to determine relationships between fatty acid (FA) species and clinical biomarkers. Despite remaining overweight/obese, interleukin (IL)-6, IL-8, TNFα, PAI-1, resistin, amylin, leptin, insulin, and IL-1ra decreased and adiponectin increased. Culture studies indicated decreases in monocyte secretion of IL-6, TNFα, and IL-1ß and adipocyte secretion of IL-6. Lipomic analysis revealed a decrease in total lipids and decreases in saturated FAs and an increase in 18:1/18:0. In general, Pearson's correlations revealed that inflammatory markers are negatively associated with a cluster of polyunsaturated FAs and positively correlated with several saturated FAs. These results indicate significant modification of multiple indices of metabolic health with short-term rigorous lifestyle modification in overweight/obese children prior to obesity reversal.


Assuntos
Adipócitos/metabolismo , Terapia por Exercício , Inflamação/terapia , Leucócitos Mononucleares/metabolismo , Sobrepeso/terapia , Adolescente , Biomarcadores/sangue , Biomarcadores/metabolismo , Glicemia/análise , Glicemia/metabolismo , Células Cultivadas , Criança , Citocinas/sangue , Citocinas/metabolismo , Jejum/sangue , Jejum/metabolismo , Ácidos Graxos/sangue , Ácidos Graxos/metabolismo , Feminino , Humanos , Masculino , Sobrepeso/sangue , Sobrepeso/metabolismo
4.
J Neuroimmunol ; 147(1-2): 82-6, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14741433

RESUMO

Lung macrophages provide a first line of host defense against inhaled pathogens and their function is impaired in the lungs of inhaled substance abusers. In order to investigate the mechanism for this impairment, alveolar macrophages (AM) were recovered from nonsmokers (NS), regular tobacco smokers (TS), marijuana smokers (MS), or crack cocaine smokers (CS), and evaluated for their production of nitric oxide (NO) and the role of NO as an antimicrobial effector molecule. AM from NS and TS efficiently killed Staphylococcus aureus and their antibacterial activity correlated closely with the production of nitrite and the expression of mRNA encoding for inducible nitric oxide synthase (iNOS). In contrast, AM collected from MS and CS exhibited limited antimicrobial activity that was not affected by an inhibitor of iNOS, or associated with expression of iNOS. Treatment with either granulocyte/macrophage colony-stimulating factor (GM-CSF) or interferon-gamma restored the ability of these cells to produce NO and to kill bacteria. These findings confirm a significant role for NO as an antibacterial effector molecule used by normal human AM and suggest that this host defense mechanism is suppressed by habitual exposure to inhaled marijuana or crack cocaine in vivo.


Assuntos
Cannabis/química , Transtornos Relacionados ao Uso de Cocaína/patologia , Cocaína/farmacologia , Macrófagos Alveolares/efeitos dos fármacos , Fumar Maconha/patologia , Adulto , Citotoxicidade Imunológica , Feminino , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Humanos , Interferon gama/farmacologia , Macrófagos Alveolares/imunologia , Masculino , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase/antagonistas & inibidores , Óxido Nítrico Sintase/genética , Óxido Nítrico Sintase/metabolismo , Óxido Nítrico Sintase Tipo II , Staphylococcus aureus
5.
Chem Phys Lipids ; 121(1-2): 229-39, 2002 Dec 31.
Artigo em Inglês | MEDLINE | ID: mdl-12505703

RESUMO

This review examines evidence that delta(9)-tetrahydrocannabinol (THC) can regulate and suppress human immune responses. Leukocytes express both cannabinoid receptor type 1 (CB1) and cannabinoid receptor type 2 (CB2), and levels of mRNA encoding for them are increased in peripheral blood leukocytes obtained from marijuana smokers, suggesting cannabinoid receptor activation in vivo. Exposure of human T-cells to THC suppresses their proliferation, inhibits the release of interferon-gamma, and skews the balance of T-helper cytokines towards a type 2 response. The majority of these effects are CB2 receptor-dependent. Consistent with an impact of THC on cell-mediated immunity, alveolar macrophages (AMs) recovered from the lungs of marijuana smokers are suppressed in their ability to release pro-inflammatory cytokines and nitric oxide (NO), and kill bacteria. Macrophage function is restored by treatment with interferon-gamma, a type 1 cytokine. Habitual exposure to THC appears capable of impacting on human cell-mediated immunity and host defense.


Assuntos
Dronabinol/farmacologia , Imunidade Celular/efeitos dos fármacos , Imunossupressores/farmacologia , Divisão Celular/efeitos dos fármacos , Divisão Celular/imunologia , Citocinas/imunologia , Citocinas/metabolismo , Dronabinol/efeitos adversos , Humanos , Imunossupressores/efeitos adversos , Interferon gama/imunologia , Interferon gama/metabolismo , Leucócitos/imunologia , Leucócitos/metabolismo , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Macrófagos/metabolismo , Óxido Nítrico/antagonistas & inibidores , Óxido Nítrico/biossíntese , Receptores de Canabinoides , Receptores de Droga/efeitos dos fármacos , Receptores de Droga/imunologia , Receptores de Droga/metabolismo , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia
6.
J Clin Pharmacol ; 42(S1): 71S-81S, 2002 11.
Artigo em Inglês | MEDLINE | ID: mdl-12412839

RESUMO

Habitual smoking of marijuana has a number of effects on the respiratory and immune systems that may be clinically relevant. These include alterations in lung function ranging from no to mild airflow obstruction without evidence of diffusion impairment, an increased prevalence of acute and chronic bronchitis, striking endoscopic findings of airway injury (erythema, edema, and increased secretions) that correlate with histopathological alterations in bronchial biopsies, and dysregulated growth of the bronchial epithelium associated with altered expression of nuclear and cytoplasmic proteins involved in the pathogenesis of bronchogenic carcinoma. Other consequences of regular marijuana use include ultrastructual abnormalities in human alveolar macrophages along with impairment of their cytokine production, antimicrobial activity, and tumoricidal function. Cannabinoid receptor expression is altered in leukocytes collected from the blood of chronic smokers, and experimental models support a role for delta9-tetrahydrocannabinol in suppressing T cell function and cell-mediated immunity. The potential for marijuana smoking to predispose to the development of respiratory malignancy is suggested by several lines of evidence, including the presence of potent carcinogens in marijuana smoke and their resulting deposition in the lung, the occurrence of premalignant changes in bronchial biopsies obtained from smokers of marijuana in the absence of tobacco, impairment of antitumor immune defenses by delta9-tetrahydrocannabinol, and several clinical case series in which marijuana smokers were disproportionately over represented among young individuals who developed upper or lower respiratory tract cancer. Additional well designed epidemiological and immune monitoring studies are required to determine the potential causal relationship between marijuana use and the development of respiratory infection and/or cancer.


Assuntos
Sistema Imunitário/efeitos dos fármacos , Fumar Maconha/efeitos adversos , Doenças Respiratórias/etiologia , Brônquios/efeitos dos fármacos , Brônquios/imunologia , Brônquios/patologia , Bronquite/etiologia , Dronabinol/toxicidade , Volume Expiratório Forçado , Humanos , Macrófagos Alveolares/efeitos dos fármacos , Macrófagos Alveolares/fisiologia , Estresse Oxidativo , Neoplasias do Sistema Respiratório/etiologia , Traqueia/efeitos dos fármacos , Traqueia/imunologia , Traqueia/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...